Corrie, P., Marshall, A., Nathan, P., Lorigan, P., Gore, M., Tahir, S., …Coltart, R. (2018). Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial. Annals of Oncology, 29(8), 1843 -1852. https://doi.org/10.1093/annonc/mdy229